| Value | ₹0.70 Cr |
|---|
BSE filing, NSE: DCW. Summary written from the filing by ALFA Finder's alert engine.
DCW Ltd: key numbers
- Share price
- ₹45.23
- Market cap
- ₹1,335 Cr
- Revenue (annual)
- ₹2,144 Cr
- Net profit (annual)
- ₹48.17 Cr
- P/E (TTM)
- 19.7×Sector 33.6×
- Promoter holding
- 45.59%+0.00% QoQ
- FII holding
- 5.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from DCW Ltd
All →DCW Promoter Buying (Off-Market)
DCW Ltd disclosed under Regulation 10(6) inter-se gift transfers of 1,09,54,611 (3.71%) shares among promoter group members Vivek Jain, Meeta Jain, Saatvik Jain and Rima Saatvik Jain. Promoter aggregate holding is unchanged and no consideration is involved.
DCW Earnings Call Transcript: Key Takeaways
Revenue grew 23% YoY despite West Asia volatility and local floods. Management pivots to specialty chemicals to counteract commoditized PVC and Soda Ash cyclic pressures.
DCW Investor Presentation: Key Takeaways
Q2 FY27 revenue +22.9% YoY to INR 6,629 Mn, but EBITDA fell 18.1% to INR 475 Mn (7.17% margin). Q2 PAT INR 104 Mn (-24.6%); H1 PAT boosted by tax credit.
DCW Capital Structure Change
DCW Limited's board approved an open-market buyback of up to 68.97 lakh shares at Rs 58 each. The maximum buyback size is Rs 40 Crore.
- Value
- ₹40.00 Cr
DCW Q2 FY27 Results: Net Profit ₹10.4 Cr, Down 24.6% YoY
DCW Ltd reported revenue from operations of ₹662.9 Cr (+22.9% YoY) and net profit of ₹10.4 Cr (-24.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹10.4 Cr · -24.6% YoY
DCW Board Meeting Date
DCW Ltd intimates a board meeting on October 29, 2026 to approve Q2 unaudited results and consider a share buyback. The trading window is closed until 48 hours after the meeting.
Other capital structure change announcements
All →Indrayani Biotech Capital Structure Change
Indrayani Biotech allotted 83,64,036 rights equity shares at Rs 15 (75,03,333 fully paid) and Rs 3.75 (8,60,703 partly paid). Issue receipts total about Rs 11.58 Crore.
- Value
- ₹11.58 Cr
Shlokka Dyes Capital Structure Change
Shlokka Dyes proposed raising its authorised capital to 2.9 crore shares, pending approval at a 28 November 2026 meeting. No fresh capital has been raised yet.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ received BSE in-principle approval for its Rights Issue and has convened a board meeting on 4 November 2026 to fix the issue price and record date. The issue was earlier approved for up to Rs 40 Crore.
NCL Research and Financial Services Capital Structure Change
GCM Capital Advisors and PACs disclosed selling 8,00,000 NCL Research shares, reducing holding to 5.49%. Non-promoter transaction, no consideration stated.
Shardul Securities Capital Structure Change
Shardul Securities extinguished 1,92,00,000 equity shares bought back in its October 2026 tender offer. Post-extinguishment paid-up capital falls to Rs.1,365.84 lakhs.
JSW Dulux Capital Structure Change
HDFC Mutual Fund schemes raised their JSW Dulux stake to 8.06% via open market buying. The stake rose 2.21% as of October 30, 2026.